可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Ruige JB, Assendelft WJ, Dekker JM, et al. Insulin and risk of cardiovascular disease[J]. Circulation,1998,97(10):996-1001.
[2]Wallin M, Barr G, Owall A, et al. The influence of glucoseinsulinpotsssium (GIK) on the GH/IGF1/IGFBP1 axis during elective coronary artery bypass surgery[J]. J Cardiothorac Vasc Anesth, 2003,17(4):470-477.
[3]Woods AA, Taegtmeyer H. Reversal of glucoseinsulinpotassiuminduced hyperglycemia by aggressive insulin treatment in postoperative heart failure. An observational study[J]. Cardiology, 2004,102(2):82-88.
[4]Ramanathan T, Shirota K, Morita S, et al. Glucoseinsulinpotassium solution improves left ventricular mechanics in diabetes[J]. Ann Thorac Surg, 2002,73(2):582-587.
[5]Guo F,Gao E,Yue TL,et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemiareperfusion:the roles of PI3kinase,Akt,and endothelial nitric oxide synthase phosphorylation[J]. Circulation,2002,105(12):1497-1502.
[6]Miles PD, Li S, Hart M, et al. Mechanisms of insulin resistance in experimental hyperinsulinemic dogs[J]. J Clin Invest, 1998,101(1):202-211.
[7]Szabo Z, Hakanson E, Maros T, et al. Highdose glucoseinsulinpotassium after cardiac surgery: a retrospective analysis of clinical safety issues[J]. Acta Anaesthesiol Scand, 2003,47(4):383-390.